USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Biologics Safety Testing Market By Product (Services, Instruments and Reagents and Kits); by Test Type (Bioburden tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Cell Line Authentication and Characterization Tests, Sterility Tests, Endotoxin Tests and Other Test Types); by Application (Tissue and Tissue-related Products Testing, Cellular and Gene Therapy, Blood and Blood-related Products Testing, Vaccine and Therapeutics Development and Stem Cell Research): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecast 2020–2026

Covid-19

Global Biologics Safety Testing Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the biologics safety testing industry. The report analyzes and declares the historical and current trends analysis of the biologics safety testing industry and subsequently recommends the projected trends anticipated to be observed in the biologics safety testing market during the upcoming years.

The biologics safety testing market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire biologics safety testing market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the biologics safety testing industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the biologics safety testing industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the biologics safety testing market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the biologics safety testing industry. The biologics safety testing market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the biologics safety testing sector. Key strategic developments in the biologics safety testing market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the biologics safety testing market are appropriately highlighted in the report.

The biologics safety testing market research report delivers an acute valuation and taxonomy of the biologics safety testing industry by practically splitting the market on the basis of different types, category, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the biologics safety testing industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the biologics safety testing industry is provided for the leading economies of the world.

Biologics products which are added to products derived from biological sources. Biologics are used in animals and humans as medical devices. Demand for the biologics safety testing market is driven by growing demand for biologics to tackle the burden of various chronic diseases, increased investment in life science research and development, rapid growth in new product launches, growth in pharmaceutical and biopharmaceutical research and increased prevalence of chronic disorders.

The global biologics safety testing market has been segmented on the basis of product, test type, and application. On the basis of product segment, the target market is segmented into reagents and kits, services, and instruments. Also, on the basis of test type segment the global market is segmented into endotoxin tests, sterility tests, cell line authentication and characterization tests, residual host contamination detection tests, adventitious agent detection tests, bioburden tests, and other tests.

Some of the essential players operating in the biologics safety testing market, but not restricted to include Merck KGaA, Pace Analytical Services Inc., Charles River Laboratories, Toxikon Corporation, Cytovance Biologics, Inc., Sartorius AG, Thermo Fisher Scientific Inc., WuXi Apptec, SGS SA, Lonza Group LTD.

logoThe taxonomy of the biologics safety testing industry by its scope and segmentation is as follows:

logo By Product

  • Reagents and Kits
  • Services
  • Instruments

logo By Test Type

  • Endotoxin Tests
  • Sterility Tests
  • Cell Line Authentication and Characterization Tests
  • Residual Host Contamination Detection Tests
  • Adventitious Agent Detection Tests
  • Bioburden tests
  • Other Tests

logo By Application

  • Vaccine and Therapeutics Development
  • Blood and Blood-related Products Testing
  • Cellular and Gene Therapy
  • Tissue and Tissue-related Products Testing
  • Stem Cell Research

logo Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Covid-19

Biologics Safety Testing Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

logoKey Insights from Primary Research

  • According to the primary CXO’s of the global biologics safety testing market, the market is estimated to witness a substantial growth of nearly 11 % over the forecast period.
  • The market was valued at USD 3.0 Billion, in 2019 and is expected to be valued over USD 6.8 Billion.
  • Asia Pacific market is expected to be the fastest goring region for biologics safety testing over the forecast period owing to growing investments for R&D in the region.
  • By geography, the North America region headed the market with a highest share in 2019.

logoKey Recommendations from Analysts

  • The strategic developments such as regional expansion, product innovations and on-going research and developments by the major companies such as Merck KGaA, Charles River Laboratories, Lonza Group LTD., Toxikon Corporation is likely to boom the market’s growth over the up-coming years.
  • Our analysts recommend that the Asia Pacific region is predicted to witness a significant growth.
  • On the basis of the product type segment, Reagents and Kits dominated the global biologics safety testing market in 2019. In terms of revenue, it accounted for significant share of the total market in 2019.
  • Strengthening the distribution channel may also help the major player to cater the lucrative growth of the market over the years to come.

logoMarket Share Analysis by Product

logoBiologics Safety Testing Market

Covid-19

Biologics Safety Testing Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  •  Merck KGaA
  •  Pace Analytical Services Inc.
  •  Charles River Laboratories
  •  Toxikon Corporation
  •  Cytovance Biologics Inc.
  •  Sartorius AG
  •  Thermo Fisher Scientific Inc.
  •  WuXi Apptec
  •  SGS SA
  • Lonza Group LTD.

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Biologics Safety Testing Market.
According to Facts and Factors research report, the global Biologics Safety Testing Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Biologics Safety Testing Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Biologics Safety Testing Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Biologics Safety Testing Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Biotechnology Instruments Market Report , 2021 – 2026

According to the report published by Facts and Factors, global demand for the biotechnology instruments market was estimated at approximately USD 41,006.2 Million in 2020 and is expected to generate revenue of around USD 80,051.1 Million by the end of 2026, growing at a CAGR of around 12.66% betwe...

Published Date : 18-Jan-2022 | | Category : | Pages : 171 | Format : Read more

Inquiry for Buying Request Sample
report img

Biosensors Market Report 2021 – 2026

[210+ Pages Report] As per the Facts and Factors market research report, the globalBiosensors market generated sales revenue of USD 21.96 Billion in 2020. Further, the Biosensors sales are expected to generate revenue of USD 34.088 Billion by the end of the year 2026, increasing at a CAGR of aroun...

Published Date : 23-Jul-2021 | | Category : | Pages : 210 | Format : Read more

Inquiry for Buying Request Sample